466 related articles for article (PubMed ID: 15958128)
1. Antibodies to peripheral nerve myelin proteins in chronic inflammatory demyelinating polyradiculoneuropathy.
Allen D; Giannopoulos K; Gray I; Gregson N; Makowska A; Pritchard J; Hughes RA
J Peripher Nerv Syst; 2005 Jun; 10(2):174-80. PubMed ID: 15958128
[TBL] [Abstract][Full Text] [Related]
2. Antibodies to LM1 and LM1-containing ganglioside complexes in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
Kuwahara M; Suzuki S; Takada K; Kusunoki S
J Neuroimmunol; 2011 Oct; 239(1-2):87-90. PubMed ID: 21914557
[TBL] [Abstract][Full Text] [Related]
3. T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
Csurhes PA; Sullivan AA; Green K; Pender MP; McCombe PA
J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1431-9. PubMed ID: 16170091
[TBL] [Abstract][Full Text] [Related]
4. Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study.
Ruts L; Drenthen J; Jacobs BC; van Doorn PA;
Neurology; 2010 May; 74(21):1680-6. PubMed ID: 20427754
[TBL] [Abstract][Full Text] [Related]
5. [Antiganglioside antibodies: when, which and for what].
Gallardo E; Rojas-García R; Belvís R; Serrano-Munuera C; Ortiz E; Ortiz N; Grau J; Illa I
Neurologia; 2001; 16(7):293-7. PubMed ID: 11485721
[TBL] [Abstract][Full Text] [Related]
6. Altered cerebrospinal fluid index of prealbumin, fibrinogen, and haptoglobin in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
Zhang HL; Zhang XM; Mao XJ; Deng H; Li HF; Press R; Fredrikson S; Zhu J
Acta Neurol Scand; 2012 Feb; 125(2):129-35. PubMed ID: 21434877
[TBL] [Abstract][Full Text] [Related]
7. Nodal proteins are target antigens in Guillain-Barré syndrome.
Devaux JJ; Odaka M; Yuki N
J Peripher Nerv Syst; 2012 Mar; 17(1):62-71. PubMed ID: 22462667
[TBL] [Abstract][Full Text] [Related]
8. Antibody responses to peptides of peripheral nerve myelin proteins P0 and P2 in patients with inflammatory demyelinating neuropathy.
Inglis HR; Csurhes PA; McCombe PA
J Neurol Neurosurg Psychiatry; 2007 Apr; 78(4):419-22. PubMed ID: 17158557
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cells in the cerebrospinal fluid and peripheral nerves in Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
Press R; Nennesmo I; Kouwenhoven M; Huang YM; Link H; Pashenkov M
J Neuroimmunol; 2005 Feb; 159(1-2):165-76. PubMed ID: 15652416
[TBL] [Abstract][Full Text] [Related]
10. Increased circulating T cell reactivity to GM1 ganglioside in patients with Guillain-Barré syndrome.
Csurhes PA; Sullivan AA; Green K; Greer JM; Pender MP; McCombe PA
J Clin Neurosci; 2005 May; 12(4):409-15. PubMed ID: 15925771
[TBL] [Abstract][Full Text] [Related]
11. Absence of antimyelin antibodies and serum demyelinating factors in most patients with chronic inflammatory demyelinating polyradiculoneuropathy.
McCombe PA; Pollard JD; McLeod JG
Clin Exp Neurol; 1988; 25():53-60. PubMed ID: 3267485
[TBL] [Abstract][Full Text] [Related]
12. Antibody responses to P0 and P2 myelin proteins in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy.
Khalili-Shirazi A; Atkinson P; Gregson N; Hughes RA
J Neuroimmunol; 1993 Jul; 46(1-2):245-51. PubMed ID: 7689591
[TBL] [Abstract][Full Text] [Related]
13. Studies of HLA associations in male and female patients with Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP).
McCombe PA; Csurhes PA; Greer JM
J Neuroimmunol; 2006 Nov; 180(1-2):172-7. PubMed ID: 16935351
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory neuropathies.
Hughes RA
Baillieres Clin Neurol; 1994 Apr; 3(1):45-72. PubMed ID: 7921591
[TBL] [Abstract][Full Text] [Related]
15. AIDP and CIDP having specific antibodies to the carbohydrate epitope (-NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4Glc-) of gangliosides.
Usuki S; Sanchez J; Ariga T; Utsunomiya I; Taguchi K; Rivner MH; Yu RK
J Neurol Sci; 2005 May; 232(1-2):37-44. PubMed ID: 15850580
[TBL] [Abstract][Full Text] [Related]
16. Antibodies in sera from patients with inflammatory demyelinating polyradiculoneuropathy react with ganglioside LM1 and sulphatide of peripheral nerve myelin.
Fredman P; Vedeler CA; Nyland H; Aarli JA; Svennerholm L
J Neurol; 1991 Apr; 238(2):75-9. PubMed ID: 1856740
[TBL] [Abstract][Full Text] [Related]
17. Autoantibody-mediated dysfunction of sympathetic neurons in guillain-barre syndrome.
Lehmann HC; Jangouk P; Kierysch EK; Meyer zu Hörste G; Hartung HP; Kieseier BC
Arch Neurol; 2010 Feb; 67(2):203-10. PubMed ID: 20142528
[TBL] [Abstract][Full Text] [Related]
18. The spectrum of acquired demyelinating polyradiculoneuropathy.
Hughes RA
Acta Neurol Belg; 1994; 94(2):128-32. PubMed ID: 8036880
[TBL] [Abstract][Full Text] [Related]
19. Anti-PMP22 antibodies in patients with inflammatory neuropathy.
Gabriel CM; Gregson NA; Hughes RA
J Neuroimmunol; 2000 May; 104(2):139-46. PubMed ID: 10713353
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of chronic inflammatory demyelinating polyradiculoneuropathy.
Hughes RA; Allen D; Makowska A; Gregson NA
J Peripher Nerv Syst; 2006 Mar; 11(1):30-46. PubMed ID: 16519780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
